thiazolidines has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ball, LE; DeAngelo, DJ; Hardiman, G; Kraft, AS; Luevano, LA; Minden, MD; Padi, SK; Song, JH; Warfel, NA | 1 |
1 other study(ies) available for thiazolidines and Leukemia, Lymphocytic, T Cell
Article | Year |
---|---|
Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Biphenyl Compounds; Cell Proliferation; Clinical Trials, Phase I as Topic; Humans; Insulin Receptor Substrate Proteins; Leukemia, Experimental; Leukemia, T-Cell; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Staging; Neoplasms; Phosphorylation; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Signal Transduction; Thiazolidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |